Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Zender

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Nature|January 31, 2014
Cancer: interference identifies immune modulatorsLars Zender
Nature Medicine|April 6, 2019
Charting a path from 'bench to bedside'Lars Zender
Gastroenterology|August 31, 2010
DLC1 and liver cancer: the Akt connectionTorsten Wuestefeld, Lars Zender
Cancer Cell|October 12, 2016
p62 in Liver Disease: Good Guy or Bad Guy?Zexi Hu, Lars Zender
Cold Spring Harbor Protocols|July 3, 2015
Reconstitution of Mice with Modified Liver Stem CellsLars Zender, Michael Hemann
Gastroenterology|August 12, 2008
Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models?Lars Zender, Stefan Kubicka
Onkologie|October 16, 2008
Molecular pathogenesis and targeted therapy of hepatocellular carcinomaLars Zender, Stefan Kubicka
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAsLars Zender, Stefan Kubicka
Carcinogenesis|April 4, 2012
Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologiesLisa Hoenicke, Lars Zender
Nature Reviews. Gastroenterology & Hepatology|January 23, 2020
Therapy-induced senescence - an induced synthetic lethality in liver cancer?Katharina Wolter, Lars Zender
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Nature|January 31, 2014
Cancer: interference identifies immune modulatorsLars Zender
Nature Medicine|April 6, 2019
Charting a path from 'bench to bedside'Lars Zender
Gastroenterology|August 31, 2010
DLC1 and liver cancer: the Akt connectionTorsten Wuestefeld, Lars Zender
Cancer Cell|October 12, 2016
p62 in Liver Disease: Good Guy or Bad Guy?Zexi Hu, Lars Zender
Cold Spring Harbor Protocols|July 3, 2015
Reconstitution of Mice with Modified Liver Stem CellsLars Zender, Michael Hemann
Gastroenterology|August 12, 2008
Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models?Lars Zender, Stefan Kubicka
Onkologie|October 16, 2008
Molecular pathogenesis and targeted therapy of hepatocellular carcinomaLars Zender, Stefan Kubicka
Methods in Molecular Biology (Clifton, N.J.)|December 19, 2006
Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAsLars Zender, Stefan Kubicka
Carcinogenesis|April 4, 2012
Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologiesLisa Hoenicke, Lars Zender
Nature Reviews. Gastroenterology & Hepatology|January 23, 2020
Therapy-induced senescence - an induced synthetic lethality in liver cancer?Katharina Wolter, Lars Zender
Pageof 20